John Glenn Iradimed Corp (IRMD) insider trading activity

John Glenn is CHIEF FINANCIAL OFFICER of IRADIMED CORP. Currently has a direct ownership of 8,460 shares of IRMD, which is worth approximately $713,601. The most recent transaction as insider was on Dec 11, 2025, when has been sold 714 shares (Common Stock) at a price of $97.38 per share, resulting in proceeds of $69,529. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.46K

35.67% 3M change

93.02% 12M change

Total Value Held $713,601

JOHN GLENN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 11 2025	SELL Payment of exercise price or tax liability	$69,529 $97.38 p/Share	714 Reduced 7.78%	8,460 Common Stock
Dec 11 2025	SELL Open market or private sale	$1,465,050 $97.67 p/Share	15,000 Reduced 67.08%	7,362 Common Stock
Dec 11 2025	BUY Exercise of conversion of derivative security	-	1,812 Added 16.49%	9,174 Common Stock
Dec 07 2025	SELL Payment of exercise price or tax liability	$1,101,740 $94.57 p/Share	11,650 Reduced 34.25%	22,362 Common Stock
Dec 07 2025	BUY Exercise of conversion of derivative security	-	31,512 Added 50.71%	30,629 Common Stock
Nov 10 2025	SELL Open market or private sale	$900,116 $84.51 p/Share	10,651 Reduced 80.99%	2,500 Common Stock
Jun 20 2025	SELL Payment of exercise price or tax liability	$82,234 $58.24 p/Share	1,412 Reduced 9.7%	13,151 Common Stock

Jun 20 2025	BUY Exercise of conversion of derivative security	-	5,796 Added 28.47%	14,563 Common Stock
Dec 02 2024	SELL Open market or private sale	$135,450 $54.18 p/Share	2,500 Reduced 36.32%	4,383 Common Stock
Jun 20 2024	SELL Payment of exercise price or tax liability	$60,052 $42.53 p/Share	1,412 Reduced 13.87%	8,767 Common Stock
Jun 20 2024	BUY Exercise of conversion of derivative security	-	5,796 Added 36.28%	10,179 Common Stock
Jun 20 2023	SELL Payment of exercise price or tax liability	$67,606 $47.88 p/Share	1,412 Reduced 17.02%	6,883 Common Stock
Jun 20 2023	BUY Exercise of conversion of derivative security	-	5,795 Added 41.13%	8,295 Common Stock
Dec 15 2022	BUY Grant, award, or other acquisition	$71,675 $28.67 p/Share	2,500 Added 50.0%	2,500 Common Stock

Also insider at

EKSO

EKSO BIONICS HOLDINGS, INC. Healthcare

Chief Financial Officer

John Glenn

CHIEF FINANCIAL OFFICER

Richmond, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IRMD shares.

Notify only if

Value

Insider Trading

Get notified when an Iradimed Corp insider buys or sells IRMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to IRADIMED CORP

Track Activities on IRMD

Account